TY - JOUR
T1 - Degradation of tyrosine hydroxylase by the ubiquitin-proteasome system in the pathogenesis of Parkinson’s disease and dopa-responsive dystonia
AU - Kawahata, Ichiro
AU - Fukunaga, Kohji
N1 - Funding Information:
This research was funded in part by the Strategic Research Program for Brain Sciences of the Japan Agency for Medical Research and Development, AMED (JP18dm0107071 and JP19dm0107071) to K.F., as well as by the Japan Society for the Promotion of Science, KAKENHI (19K07097), Kobayashi Foundation, and Intelligent Cosmos Academic Foundation to I.K.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Nigrostriatal dopaminergic systems govern physiological functions related to locomotion, and their dysfunction leads to movement disorders, such as Parkinson’s disease and dopa-responsive dystonia (Segawa disease). Previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (TH), a rate-limiting enzyme of dopamine biosynthesis, is reduced in Parkinson’s disease and dopa-responsive dystonia; however, the mechanism of TH depletion in these disorders remains unclear. In this article, we review the molecular mechanism underlying the neurodegeneration process in dopamine-containing neurons and focus on the novel degradation pathway of TH through the ubiquitin-proteasome system to advance our understanding of the etiology of Parkinson’s disease and dopa-responsive dystonia. We also introduce the relation of α-synuclein propagation with the loss of TH protein in Parkinson’s disease as well as anticipate therapeutic targets and early diagnosis of these diseases.
AB - Nigrostriatal dopaminergic systems govern physiological functions related to locomotion, and their dysfunction leads to movement disorders, such as Parkinson’s disease and dopa-responsive dystonia (Segawa disease). Previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (TH), a rate-limiting enzyme of dopamine biosynthesis, is reduced in Parkinson’s disease and dopa-responsive dystonia; however, the mechanism of TH depletion in these disorders remains unclear. In this article, we review the molecular mechanism underlying the neurodegeneration process in dopamine-containing neurons and focus on the novel degradation pathway of TH through the ubiquitin-proteasome system to advance our understanding of the etiology of Parkinson’s disease and dopa-responsive dystonia. We also introduce the relation of α-synuclein propagation with the loss of TH protein in Parkinson’s disease as well as anticipate therapeutic targets and early diagnosis of these diseases.
KW - Dopa-responsive dystonia
KW - Fatty acid-binding protein 3
KW - Parkinson’s disease
KW - Proteasomal degradation
KW - Tyrosine hydroxylase
KW - Ubiquitin-proteasome system
KW - Ubiquitination
KW - α-synuclein
UR - http://www.scopus.com/inward/record.url?scp=85085904521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085904521&partnerID=8YFLogxK
U2 - 10.3390/ijms21113779
DO - 10.3390/ijms21113779
M3 - Review article
C2 - 32471089
AN - SCOPUS:85085904521
SN - 1422-0067
VL - 21
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 11
M1 - 3779
ER -